siRNA-based breast cancer therapy by suppressing 17β-hydroxysteroid dehydrogenase type 1 in an optimized xenograft cell and molecular biology model in vivo

References

• SiegelRLMillerKDJemalACancer statistics, 2016CA Cancer J Clin201666173026742998
   PubMed Web of Science ®Google Scholar
• Center for disease control and preventionWhat Are The Risk Factors For Breast Cancer? Available from: https://www.cdc.gov/cancer/breast/basic_info/risk_factorshtmAccessed 9 Mar 2017
   Google Scholar
• AkaJACalvoELLinSXEstradiol-independent modulation of breast cancer transcript profile by 17 beta-hydroxysteroid dehydrogenase type 1Mol Cell Endocrinol201743917518627544780
   PubMed Web of Science ®Google Scholar
• AkaJAZerradiMHouleFHuotJLinSX17beta-hydroxysteroid dehydrogenase type 1 modulates breast cancer protein profile and impacts cell migrationBreast Cancer Res2012143R9222691413
   PubMed Web of Science ®Google Scholar
• HeWGauriMLiTWangRLinSXCurrent knowledge of the multifunctional 17β-hydroxysteroid dehydrogenase type 1 (HSD17B1)Gene20165881546127102893
   PubMed Web of Science ®Google Scholar
• BrozicPLanisnik RisnerTGobecSInhibitors of 17beta-hydroxysteroid dehydrogenase type 1Curr Med Chem200815213715018220769
   PubMed Web of Science ®Google Scholar
• LukacikPKavanaghKLOppermannUStructure and function of human 17beta-hydroxysteroid dehydrogenasesMol Cell Endocrinol20062481–2617116414178
   PubMed Web of Science ®Google Scholar
• ZhangCYChenJYinDCLinSXThe contribution of 17beta-hydroxysteroid dehydrogenase type 1 to the estradiolestrone ratio in estrogen-sensitive breast cancer cellsPLoS One201271e2983522253796
   PubMed Web of Science ®Google Scholar
• KocbekPTeskacKBrozicPRiznerTGobecSKristlJEffect of free and in poly(η-caprolactone) nanoparticles incorporated new type 1 17β-hydroxysteroid dehydrogenase inhibitors on cancer cellsCurrent Nanoscience2010616976
   Web of Science ®Google Scholar
• HusenBHuhtinenKSaloniemiTMessingerJTholeHHPoutanenMHuman hydroxysteroid (17-beta) dehydrogenase 1 expression enhances estrogen sensitivity of MCF-7 breast cancer cell xenograftsEndocrinology2006147115333533916916945
   PubMed Web of Science ®Google Scholar
• HilbornEStålOJanssonAEstrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancerOncotarget2017818305523056228430630
   PubMedGoogle Scholar
• LinSXPoirierDAdamskiJA challenge for medicinal chemistry by the 17β-hydroxysteroid dehydrogenase superfamily: an integrated biological function and inhibition studyCurr Top Med Chem201313101164117123647539
   PubMed Web of Science ®Google Scholar
• ZhuDWLeeXBretonRCrystallization and preliminary X-ray diffraction analysis of the complex of human placental 17 beta-hydroxysteroid dehydrogenase with NADP+J Mol Biol199323412422448230203
   PubMed Web of Science ®Google Scholar
• GhoshDPletnevVZZhuDWStructure of human estrogenic 17 beta-hydroxysteroid dehydrogenase at 2.20 A resolutionStructure1995355035137663947
   PubMed Web of Science ®Google Scholar
• GhoshDWawrzakZPletnevVMolecular mechanism of inhibition of steroid dehydrogenases by licorice-derived steroid analogs in modulation of steroid receptor functionAnn N Y Acad Sci19957613413437625731
   PubMed Web of Science ®Google Scholar
• AzziARehsePHZhuDWCampbellRLLabrieFLinSXCrystal structure of human estrogenic 17 beta-hydroxysteroid dehydrogenase complexed with 17 beta-estradiolNat Struct Biol1996386656688756321
   PubMedGoogle Scholar
• GangloffAShiRNahoumVLinSXPseudo-symmetry of C19 steroids, alternative binding orientations, and multispecificity in human estrogenic 17beta-hydroxysteroid dehydrogenaseFaseb J200317227427612490543
   PubMed Web of Science ®Google Scholar
• QiuWCampbellRLGangloffAA concerted, rational design of type 1 17beta-hydroxysteroid dehydrogenase inhibitors: estradiol-adenosine hybrids with high affinityFaseb J200216131829183112223444
   PubMed Web of Science ®Google Scholar
• MazumdarMFournierDZhuDWCadotCPoirierDLinSXBinary and ternary crystal structure analyses of a novel inhibitor with 17beta-HSD type 1: a lead compound for breast cancer therapyBiochem J2009424335736619929851
   PubMed Web of Science ®Google Scholar
• DimNPerepelyukMGomesONovel targeted siRNA-loaded hybrid nanoparticles: preparation, characterization and in vitro evaluationJ Nanobiotechnology2015136126410728
   PubMed Web of Science ®Google Scholar
• VaissièreAAldrianGKonateKA retro-inverso cell-penetrating peptide for siRNA deliveryJ Nanobiotechnology20171513428454579
   PubMed Web of Science ®Google Scholar
• GoldbergMSsiRNA delivery for the treatment of ovarian cancerMethods20136329510023403216
   PubMed Web of Science ®Google Scholar
• AkaJAMazumdarMChenCQPoirierDLinSX17beta-hydroxysteroid dehydrogenase type 1 stimulates breast cancer by dihydrotestosterone inactivation in addition to estradiol productionMol Endocrinol201024483284520172961
   PubMedGoogle Scholar
• ZhangCYWangWQChenJLinSXReductive 17beta-hydroxysteroid dehydrogenases which synthesize estradiol and inactivate dihydrotestosterone constitute major and concerted players in ER+ breast cancer cellsJ Steroid Biochem Mol Biol2015150243425257817
   PubMed Web of Science ®Google Scholar
• Marchais-OberwinklerSHennCMöllerG17β-Hydroxysteroid dehydrogenases (17β-HSDs) as therapeutic targets: protein structures, functions, and recent progress in inhibitor developmentJ Steroid Biochem Mol Biol20111251–2668221193039
   PubMed Web of Science ®Google Scholar
• HusenBHuhtinenKPoutanenMKangasLMessingerJTholeHEvaluation of inhibitors for 17beta-hydroxysteroid dehydrogenase type 1 in vivo in immunodeficient mice inoculated with MCF-7 cells stably expressing the recombinant human enzymeMol Cell Endocrinol20062481–210911316406284
   PubMed Web of Science ®Google Scholar
• PiktelENiemirowiczKWątekMWollnyTDeptułaPBuckiRRecent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapyJ Nanobiotechnology20161413927229857
   PubMed Web of Science ®Google Scholar
• PengHYangHSongLSustained delivery of siRNA/PEI complex from in situ forming hydrogels potently inhibits the proliferation of gastric cancerJ Exp Clin Cancer Res2016355727029190
   PubMed Web of Science ®Google Scholar
• DayJMFosterPATutillHJ17beta-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancerInt J Cancer200812291931194018183589
   PubMed Web of Science ®Google Scholar
• LiSRizzoMABhattacharyaSHuangLCharacterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene deliveryGene Ther1998579309379813664
   PubMed Web of Science ®Google Scholar
• ChenYWuJJHuangLNanoparticles targeted with NGR motif deliver c-myc siRNA and doxorubicin for anticancer therapyMol Ther201018482883420068551
   PubMed Web of Science ®Google Scholar
• IraharaNMiyoshiYTaguchiTTamakiYNoguchiSQuantitative analysis of aromatase, sulfatase and 17beta-HSD(1) mRNA expression in soft tissue metastases of breast cancerCancer Lett20062431233116556483
   PubMed Web of Science ®Google Scholar
• LaplanteYRancourtCPoirierDRelative involvement of three 17beta-hydroxysteroid dehydrogenases (types 1, 7 and 12) in the formation of estradiol in various breast cancer cell lines using selective inhibitorsMol Cell Endocrinol20093011–214615318812208
   PubMed Web of Science ®Google Scholar
• PoutanenMMoncharmontBVihkoR17 beta-hydroxysteroid dehydrogenase gene expression in human breast cancer cells: regulation of expression by a progestinCancer Res19925222902941728403
   PubMed Web of Science ®Google Scholar
• YueWBrodieAMCF-7 human breast carcinomas in nude mice as a model for evaluating aromatase inhibitorsJ Steroid Biochem Mol Biol1993444–66716738476781
   PubMed Web of Science ®Google Scholar
• MeyerTMarshallJFHartIRExpression of alphav integrins and vitronectin receptor identity in breast cancer cellsBr J Cancer19987745305369484807
   PubMed Web of Science ®Google Scholar
• PerksCMNewcombPVNormanMRHollyJMEffect of insulin-like growth factor binding protein-1 on integrin signalling and the induction of apoptosis in human breast cancer cellsJ Mol Endocrinol199922214115010194517
   PubMed Web of Science ®Google Scholar
• NieberlerMReuningUReichartFExploring the role of RGD-recognizing integrins in cancerCancers (Basel)201799E11628869579
   PubMed Web of Science ®Google Scholar
• WikipediaNude Mouse2014 Available from: https://en.wikipedia.org/wiki/Nude_mouseAccessed October 17, 2018
   Google Scholar
• ErshlerWBThe change in aggressiveness of neoplasms with ageGeriatrics198742199103
   PubMed Web of Science ®Google Scholar
• GravekampCSypniewskaRGaunttSTarangoMPricePReddickRBehavior of metastatic and nonmetastatic breast tumors in old miceExp Biol Med (Maywood)2004229766567515229361
   PubMed Web of Science ®Google Scholar
• CariatiMMarlowRDontuGXenotransplantation of breast cancersMethods Mol Biol201173147148221516430
   PubMedGoogle Scholar